Opus Point Partners Management as of Dec. 31, 2014
Portfolio Holdings for Opus Point Partners Management
Opus Point Partners Management holds 57 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Proshares Tr pshs ult nasb (BIB) | 4.7 | $4.8M | 38k | 125.50 | |
| Incyte Corporation (INCY) | 4.4 | $4.5M | 61k | 73.10 | |
| BioMarin Pharmaceutical (BMRN) | 3.9 | $4.0M | 44k | 90.39 | |
| SPDR S&P Biotech (XBI) | 3.8 | $3.9M | 21k | 186.44 | |
| Celgene Corporation | 3.6 | $3.7M | 33k | 111.86 | |
| Nektar Therapeutics (NKTR) | 3.6 | $3.7M | 237k | 15.50 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $3.5M | 8.7k | 410.29 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $3.5M | 29k | 118.81 | |
| Illumina (ILMN) | 3.3 | $3.4M | 18k | 184.57 | |
| Alexion Pharmaceuticals | 3.3 | $3.4M | 18k | 185.03 | |
| Cepheid | 3.2 | $3.3M | 60k | 54.14 | |
| Biogen Idec (BIIB) | 3.1 | $3.2M | 9.5k | 339.55 | |
| Pharmacyclics | 3.1 | $3.1M | 26k | 122.26 | |
| Medivation | 3.1 | $3.1M | 31k | 99.60 | |
| Mettler-Toledo International (MTD) | 3.0 | $3.0M | 10k | 302.50 | |
| Receptos | 2.8 | $2.8M | 23k | 122.50 | |
| ISIS Pharmaceuticals | 2.8 | $2.8M | 45k | 61.74 | |
| Amgen (AMGN) | 2.7 | $2.7M | 17k | 159.27 | |
| Qiagen | 2.6 | $2.7M | 114k | 23.46 | |
| Seattle Genetics | 2.6 | $2.6M | 82k | 32.12 | |
| Bio-techne Corporation (TECH) | 2.5 | $2.6M | 28k | 92.40 | |
| United Therapeutics Corporation (UTHR) | 2.4 | $2.5M | 19k | 129.53 | |
| Salix Pharmaceuticals | 2.0 | $2.1M | 18k | 114.92 | |
| Synageva Biopharma | 1.8 | $1.9M | 20k | 92.79 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $1.7M | 18k | 97.01 | |
| Clovis Oncology | 1.5 | $1.5M | 27k | 56.00 | |
| Hologic (HOLX) | 1.4 | $1.4M | 53k | 26.74 | |
| XenoPort | 1.3 | $1.3M | 152k | 8.77 | |
| D Stemline Therapeutics | 1.2 | $1.2M | 70k | 17.06 | |
| Alkermes (ALKS) | 1.1 | $1.1M | 20k | 58.58 | |
| Illumina Inc option | 1.0 | $1.0M | 250.00 | 4000.00 | |
| Tenax Therapeutics | 0.9 | $956k | 249k | 3.84 | |
| Array BioPharma | 0.9 | $946k | 200k | 4.73 | |
| Kalobios Pharmaceuticals | 0.9 | $945k | 547k | 1.73 | |
| Vericel (VCEL) | 0.8 | $861k | 283k | 3.04 | |
| Momenta Pharmaceuticals | 0.8 | $843k | 70k | 12.04 | |
| Celladon | 0.8 | $828k | 42k | 19.52 | |
| Merrimack Pharmaceuticals In | 0.8 | $814k | 72k | 11.30 | |
| Incyte Corp option | 0.8 | $800k | 886.00 | 903.03 | |
| Ocera Therapeutics | 0.8 | $781k | 123k | 6.37 | |
| Chimerix (CMRX) | 0.8 | $771k | 19k | 40.26 | |
| Flamel Technologies | 0.7 | $716k | 42k | 17.13 | |
| Xencor (XNCR) | 0.7 | $717k | 45k | 16.04 | |
| Acelrx Pharmaceuticals | 0.7 | $673k | 100k | 6.73 | |
| Cubist Pharmaceuticals | 0.6 | $655k | 6.5k | 100.74 | |
| Achillion Pharmaceuticals | 0.6 | $613k | 50k | 12.26 | |
| Arrowhead Research | 0.6 | $606k | 82k | 7.38 | |
| NPS Pharmaceuticals | 0.5 | $553k | 16k | 35.74 | |
| Biogen Idec Inc option | 0.5 | $554k | 120.00 | 4620.00 | |
| Epizyme | 0.5 | $535k | 28k | 18.88 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $495k | 4.4k | 112.09 | |
| Gilead Sciences (GILD) | 0.4 | $408k | 4.3k | 94.27 | |
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 0.3 | $355k | 100.00 | 3550.00 | |
| Repros Therapeutics Inc *w exp 02/04/201 | 0.3 | $353k | 69k | 5.15 | |
| XOMA CORP Common equity shares | 0.3 | $287k | 80k | 3.59 | |
| Pharmacyclics Inc Cmn Stock cmn | 0.0 | $37k | 150.00 | 246.67 | |
| EXACT Sciences Corporation (EXAS) | 0.0 | $6.0k | 50.00 | 120.00 |
